Diagnosing and preventing iron overload (Q39192941)

9 September 2017

title

Diagnosing and preventing iron overload (English)

1 reference

9 September 2017

2

1 reference

9 September 2017

Paolo Ferrari

3

0 references

author name string

Ganesh Ramanathan

series ordinal

1

1 reference

9 September 2017

publication date

22 March 2017

1 reference

Hemodialysis International

9 September 2017

published in

1 reference

9 September 2017

volume

21 Suppl 1

1 reference

9 September 2017

page(s)

S58-S67

1 reference

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

9 September 2017

cites work

1 reference

Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients

21 January 2018

1 reference

Factors predicting erythropoietin resistance among maintenance hemodialysis patients.

21 January 2018

1 reference

Iron metabolism in the anaemia of chronic renal failure. Effects of dialysis and of parenteral iron

21 January 2018

1 reference

Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients

21 January 2018

1 reference

Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.

21 January 2018

1 reference

21 January 2018

Hepcidin for clinicians

1 reference

Hepcidin--a potential novel biomarker for iron status in chronic kidney disease

21 January 2018

1 reference

KHA-CARI Guideline: use of iron in chronic kidney disease patients

21 January 2018

1 reference

Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference

21 January 2018

1 reference

Hepcidin regulation: ironing out the details

21 January 2018

1 reference

21 January 2018

1 reference

The regulation of cellular iron metabolism

21 January 2018

1 reference

Hepcidin: regulation of the master iron regulator

21 January 2018

1 reference

Hereditary hemochromatosis in the post-HFE era

21 January 2018

1 reference

Identification of erythroferrone as an erythroid regulator of iron metabolism

21 January 2018

1 reference

Hepcidin in human iron disorders: diagnostic implications

21 January 2018

1 reference

Annual Iron Loss Associated with Hemodialysis

21 January 2018

1 reference

Iron requirements in hemodialysis

21 January 2018

1 reference

A randomized controlled study of iron supplementation in patients treated with erythropoietin

21 January 2018

1 reference

Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement

21 January 2018

1 reference

KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.

21 January 2018

1 reference

Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale.

21 January 2018

1 reference

The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?

21 January 2018

1 reference

The adverse effect of iron repletion on the course of certain infections

21 January 2018

1 reference

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

21 January 2018

1 reference

The DOPPS Practice Monitor for US dialysis care: trends through August 2011.

21 January 2018

1 reference

Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

Safety concerns about intravenous iron therapy in patients with chronic kidney disease

21 January 2018

1 reference

Time-dependent associations between iron and mortality in hemodialysis patients

21 January 2018

1 reference

Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation

21 January 2018

1 reference

Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease

21 January 2018

1 reference

Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients

21 January 2018

1 reference

Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study

21 January 2018

1 reference

Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients

21 January 2018

1 reference

Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients

21 January 2018

1 reference

Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality

21 January 2018

1 reference

Iron toxicity: relevance for dialysis patients

21 January 2018

1 reference

Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis

21 January 2018

1 reference

Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease

21 January 2018

1 reference

Iron in arterial plaque: modifiable risk factor for atherosclerosis

21 January 2018

1 reference

Testing the iron hypothesis in a mouse model of atherosclerosis

21 January 2018

1 reference

Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients

21 January 2018

1 reference

The safety of intravenous iron preparations: systematic review and meta-analysis

21 January 2018

1 reference

Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection

21 January 2018

1 reference

Assessing iron status: beyond serum ferritin and transferrin saturation

21 January 2018

1 reference

Percentage hypochromic red cells and the response to intravenous iron therapy in anaemic haemodialysis patients.

21 January 2018

1 reference

The Content of Reticulocyte Hemoglobin and Serum Concentration of the Soluble Transferrin Receptor for Diagnostics of Anemia in Chronically Hemodialyzed Patients.

21 January 2018

1 reference

Hepatic iron concentration and total body iron stores in thalassemia major.

21 January 2018

1 reference

MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients

21 January 2018

1 reference

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

21 January 2018

1 reference

Iron overload in the liver diagnostic and quantification

21 January 2018

1 reference

Single spin-echo proton transverse relaxometry of iron-loaded liver

21 January 2018

1 reference

Non-invasive assessment of hepatic iron stores by MRI.

21 January 2018

1 reference

R2* magnetic resonance imaging of the liver in patients with iron overload

21 January 2018

1 reference

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

21 January 2018

1 reference

Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis

21 January 2018

1 reference

Sudden cardiac death in hemodialysis patients: an in-depth review

21 January 2018

1 reference

Diagnostic value of iron indices in hemodialysis patients receiving epoetin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HDI.12555

1 reference

release_kd6ga3yf6ndmtgwgsxbphtkzaq

9 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kd6ga3yf6ndmtgwgsxbphtkzaq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference